Renovaro

Renovaro

Biotechnology
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

$56.2M

Market Cap • 5/23/2025

2011

(14 years)

Founded

2014

(11 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Los Angeles

Headquarters • California